Plasma concentrations and the time-course of beta blockade due to propranolol
- PMID: 1169
- DOI: 10.1002/cpt1975186708
Plasma concentrations and the time-course of beta blockade due to propranolol
Abstract
The effectiveness of intravenously administered propranolol in antagonizing the chronotropic effect of isoproterenol and exercise has been investigated, and has been found at all times to be a predictable function of its plasma concentrations according to the classical drug-receptor theory for competitive antagonism. The data show further that the relationship between effectiveness and time depends on the way in which antagonism is measured. If the dose ratio to isoproterenol (DR) is measured, then (DR-1) declines with time in parallel with drug concentration. On the other hand, if propranolol's effects are measured as percentage reduction in a given response, then this declines linearly with time, even though plasma concentrations decline exponentially. This fact explains why confusion has in the past arisen concerning the relationship of the duration of beta blockade and pharmacokinetic half-life.
Similar articles
-
Duration of cardiac effects of timolol and propranolol.Clin Pharmacol Ther. 1976 Feb;19(2):148-52. doi: 10.1002/cpt1976192148. Clin Pharmacol Ther. 1976. PMID: 4254 Clinical Trial.
-
Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.Clin Pharmacol Ther. 1972 Mar-Apr;13(2):181-5. doi: 10.1002/cpt1972132181. Clin Pharmacol Ther. 1972. PMID: 4401564 No abstract available.
-
Assessment of beta-blocking activity of trimepranol in man.Int J Clin Pharmacol Biopharm. 1978 Jun;16(6):279-84. Int J Clin Pharmacol Biopharm. 1978. PMID: 27464
-
Propranolol.Dis Mon. 1974 Oct:1-31. doi: 10.1016/s0011-5029(74)80002-7. Dis Mon. 1974. PMID: 4606956 Review. No abstract available.
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
Cited by
-
Clinical relevance of pharmacokinetics.Clin Pharmacokinet. 1980 Mar-Apr;5(2):105-36. doi: 10.2165/00003088-198005020-00001. Clin Pharmacokinet. 1980. PMID: 6102499 Review. No abstract available.
-
Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.Br J Clin Pharmacol. 1981 Nov;12(5):721-4. doi: 10.1111/j.1365-2125.1981.tb01295.x. Br J Clin Pharmacol. 1981. PMID: 6120711 Free PMC article. Clinical Trial.
-
Concentration-effect relationship of oxprenolol in healthy volunteers: a retrospective analysis.Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):143S-149S. doi: 10.1111/j.1365-2125.1985.tb02755.x. Br J Clin Pharmacol. 1985. PMID: 4005116 Free PMC article.
-
Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers.J Pharmacokinet Biopharm. 1987 Dec;15(6):569-82. doi: 10.1007/BF01068413. J Pharmacokinet Biopharm. 1987. PMID: 3450842
-
Clinical pharmacokinetics of atenolol--a review.Eur J Drug Metab Pharmacokinet. 1982;7(2):81-91. doi: 10.1007/BF03188723. Eur J Drug Metab Pharmacokinet. 1982. PMID: 6749509 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous